No Data
No Data
Day One Biopharmaceuticals(DAWN.US) Officer Sells US$378.59K in Common Stock
$Day One Biopharmaceuticals(DAWN.US)$ Officer Blackman Samuel C. sold 30,000 shares of common stock on Jun 10, 2024 at an average price of $12.6196 for a total value of $378.59K.Source: Announcement W
Day One Biopharmaceuticals Insider Sold Shares Worth $378,588, According to a Recent SEC Filing
Samuel C. Blackman, Head of R&D, on June 10, 2024, sold 30,000 shares in Day One Biopharmaceuticals (DAWN) for $378,588. Following the Form 4 filing with the SEC, Blackman has control over a total of
Express News | XOMA Disclosed It Had Received An $8.1M Milestone Payment From Viracta Therapeutics, Inc., Related To Day One Biopharmaceuticals' Recent Sale Of Its Priority Review Voucher (Prv) For $108MTo An Undisclosed Buyer
Express News | XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of Its Priority Review Voucher
Form 144 | Day One Biopharmaceuticals(DAWN.US) Officer Proposes to Sell 383.1K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 10, $Day One Biopharmaceuticals(DAWN.US)$ Officer SAMUEL BLACKMAN intends to sell 30,000 shares of its common stock on Jun 10, with a total market value of approximately $3
Analysts Are Bullish on Top Healthcare Stocks: Biomea Fusion (BMEA), Day One Biopharmaceuticals (DAWN)
QM137over1 : Friend, is there any good news from the Federal Reserve
TrytosaveabitOP QM137over1: Not yet! Supposed to release CPI at 8:30 AM est and Powell is supposed to speak about 2:30 PM est! Fingers crossed